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ABSTRACT 38 
Background and aims 39 
Little is known about the long term economic consequences of smoking during pregnancy. We 40 
estimated the association between smoking in pregnancy and the costs of delivering healthcare 41 
to infants and children, and investigated which aspects of care are the key drivers of these costs. 42 
 43 
Methods 44 
We used Hospital Episode Statistics (HES) linked with Clinical Practice Research Datalink 45 
(CPRD) data in England in children with longitudinal data for at least one, five and ten years 46 
after birth. Poisson regression provided rate ratios (RR) and 95% confidence intervals (CIs) 47 
comparing healthcare episode rates between those exposed and not exposed to smoking during 48 
pregnancy. Linear regression was used to compare estimated costs between groups (£ sterling, 49 
2015 prices) and generalized linear multivariable (GLM) models adjusted for potentially 50 
moderating factors. 51 
 52 
Results 53 
A total of 93,152 singleton pregnancies with the required data were identified. Maternal 54 
smoking in pregnancy was associated with higher primary care, prescription and hospital 55 
inpatient episode rates, but lower outpatient visit and diagnostic test rates. Adjusting for year 56 
of birth, socio-economic deprivation, parity, sex of child and delivery method showed that 57 
maternal smoking in pregnancy was associated with increased child healthcare costs at 1 year 58 
(average cost difference for children of smokers, β: £91.18, 95%CI: £47.52-£134.83) and 5 59 
years of age (β: £221.80, 95%CI: £17.78-£425.83), but not at 10 years of age (β: £365.94, 60 
95%CI: -£192.72-£924.60). 61 
 62 
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Conclusion 63 
Maternal smoking in pregnancy is associated with increased total healthcare utilisation and 64 
increased child healthcare costs over the first five years of life; these costs are primarily driven 65 
by increased numbers of hospital admissions.66 
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INTRODUCTION 67 
In Europe, the prevalence of smoking during pregnancy has been estimated to vary from 4.2% 68 
in Iceland to 18.9% in Croatia.(1) Maternal smoking during pregnancy is associated with many 69 
adverse infant and child outcomes, including an elevated risk of asthma, respiratory illness, 70 
sudden infant death syndrome (SIDS), behavioural difficulties (ADHD), preterm delivery and 71 
low birth weight, as well as poor maternal outcomes such as ectopic pregnancy and 72 
miscarriage.(2-4) These adverse sequelae are likely to increase the costs of health care for 73 
children born to pregnant smokers.  74 
 75 
Few studies have quantified the additional burden on health care services for infants and 76 
children, which is attributable to smoking in pregnancy.(5-9) Godfrey et al. estimated the 77 
additional smoking-related costs to the UK National Health Service (NHS) incurred by infants 78 
during the first 12 months of life as between £12 and £23.5 million annually (2006 prices).(7) 79 
However, this work used literature-based estimates for costs arising from only selected 80 
morbidities believed to be associated with smoking rather than deriving cost estimates for all 81 
healthcare use. Petrou et al. used medical record linkage to investigate children’s excess 82 
hospital inpatient costs attributable to smoking in pregnancy during their first five years of life, 83 
(9) and similarly other studies investigating this subject have been restricted to estimating 84 
specific elements of overall healthcare use such as neonatal intensive care admissions or health 85 
care during very early childhood.(5, 6, 8) We could find no studies which investigated infants’ 86 
and children’s healthcare costs attributable to smoking in pregnancy, which included a 87 
consideration of most healthcare episodes including those in hospital outpatient and primary 88 
care.  89 
 90 
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The primary aim of this paper was to estimate the impact of maternal smoking during 91 
pregnancy on the total cost of providing healthcare services for children. This was carried out 92 
using English data from the UK National Health Service (NHS), a public provider of care in 93 
England, Scotland, Wales and Northern Ireland. The government’s annual NHS budget is over 94 
£90 billion and care is provided free at the point of use.(10) The structure varies in individual 95 
countries, but all provide primary (community care, General Practitioners, Pharmacists), 96 
secondary (hospital based access via referral) and tertiary (specialist hospital facilities) 97 
care.(10) We used long-term, comprehensive, prospective and routinely-collected data to 98 
investigate children’s use and cost of general practitioner services, including consultations, 99 
prescriptions and diagnostic tests, along with hospital care services. Our secondary aim was to 100 
determine the distribution of costs borne by primary and secondary care providers.101 
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METHODS 102 
Data sources 103 
UK-wide Clinical Practice Research Datalink (CPRD),(11) Hospital Episode Statistics 104 
(HES),(12) Office for National Statistics (ONS) mortality data(13) and Index of Multiple 105 
Deprivation (IMD) data were used (linked data provided by CPRD).(14) The study was 106 
approved by the CPRD Independent Scientific Advisory Committee (ISAC, protocol number: 107 
15_186R). CPRD contains over 13 million anonymised primary care medical records from 684 108 
UK general practices; prospectively collected records are available from 1987. Linked records 109 
are available for approximately 10 million patients in 398 practices. Linked HES inpatient data 110 
are available from 1997, linked HES outpatient data from 2003 and ONS mortality data from 111 
1998 onwards. The IMD is an indicator of deprivation socioeconomic status (SES) based on 112 
census information from the patients’ home postcodes grouped into lower super output areas 113 
(LSOA); each LSOA covers approximately 1500 residents/650 households.  114 
 115 
Cohort of children born to pregnant smokers and non-smokers 116 
We included children born in England following singleton pregnancies who had up-to-standard 117 
linked CPRD-HES data, with at least 1 year, 5 years or 10 years of follow-up from birth and 118 
whose mothers were aged 13-49 years at delivery. Mothers and children were identified first 119 
from the CPRD Mother-Baby link; we included women with a CPRD record of smoking status 120 
or use of smoking cessation medications in pregnancy. As records of smoking status in 121 
pregnancy are generally valid,(15) we were confident that using these attributions of exposure 122 
or non-exposure to smoking in pregnancy would be generally correct. The study ran from 123 
January 2003 until January 2015 when both inpatient and outpatient CPRD-linked HES data 124 
were available. Data on delivery method, parity, gestation and delivery dates, sex of the baby, 125 
and IMD were extracted from HES. Children’s duration of follow-up was measured from birth 126 
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until death, transfer out of a CPRD general practice or the end of the study period, whichever 127 
was earliest and individual children had data available for different lengths of time. To 128 
minimise any cluster effects, if a woman had more than one child during the follow-up period 129 
only one was randomly-selected for inclusion.  130 
 131 
Exposure definitions 132 
Smoking in pregnancy: Children were considered exposed to smoking in pregnancy when born 133 
to women who, between conception and delivery, had one or more smoking Medcodes or 134 
Multilex codes for smoking cessation medication prescriptions (i.e. NRT, Bupropion, 135 
Varenicline) recorded in CPRD. This method has been used previously in a study using The 136 
Health Improvement Network (THIN) database.(16)  137 
 138 
Not smoking in pregnancy: Children were considered not exposed to smoking in pregnancy if 139 
their mother had a Medcode for being a non-smoker (including ex-smokers) recorded in CPRD 140 
during the gestational period. Consistent with the guidelines for attributing smoking status used 141 
by the UK Quality and Outcomes Framework (QOF),(17) women were also considered non-142 
smokers if they were recorded as such at least three times before the age of 25, or before 143 
becoming pregnant, had been recorded as an ex-smoker in three or more consecutive years. 144 
Additionally, during pregnancy, women could not be issued with smoking pharmacotherapy 145 
prescriptions.  146 
 147 
Primary care consultation costing 148 
Different primary care events held with the a healthcare professional on the same date were 149 
classified as one consultation and costs were attributed to consultations using the 2015 Personal 150 
Social Services Research Unit (PSSRU) reference costs;(18) attribution was based on the type 151 
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of healthcare professional providing the consultation (see below) and the consultation setting 152 
(i.e. Surgery, Home visit, Clinic, Out of hours, Telephone). Primary healthcare consultations 153 
were defined as those with GP partners/senior partners, registrars, locums or sole practitioners; 154 
community/practice nurses and dispensers/pharmacists. PSSRU unit costs include 155 
consultations’ administrative costs, so consultations recorded as having been with 156 
administrative staff were excluded. Where the 2015 PSSRU unit cost compendium provided 157 
no unit cost for a provider and setting combination, this was instead taken from the most recent 158 
PSSRU unit cost compendia and adjusted to 2015 prices using the NHS Hospital and 159 
Community Health Services Pay and Price Index.(18) 160 
 161 
Prescription costing 162 
We recorded children’s prescription items and used the British National Formulary (BNF) to 163 
cost prescriptions at the BNF chapter subparagraph level.(19) BNF chapters relate to body 164 
systems, BNF sections to prescribing for systems, and paragraph and subparagraph levels relate 165 
to the pharmacology and therapeutic use. The Prescription Cost Analysis (PCA) database for 166 
2015(20) was used to attribute all prescription costs, irrespective of the year in which they were 167 
issued. Where the 2015 PCA database did not specify costs for items prescribed (32.3% of all 168 
prescriptions), the average 2015 PCA prescription cost (£30.96) was used.  169 
 170 
Primary care diagnostic test costing 171 
Children’s diagnostic tests in the CPRD test file were identified and included. Costs for 172 
diagnostic tests were based on those listed in the National Schedule of Reference Costs (2015) 173 
for direct access pathology and diagnostic services.(18) Average costs were assigned for 174 
asthma tests (e.g. lung function/ spirometry), biochemistry (e.g. hormone, thyroid function, 175 
electrolytes), diabetic retinopathy, diagnostic imaging (e.g. chest x-ray), haematology (e.g. full 176 
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blood count, clotting tests), microbiology (e.g. stool culture, sputum culture), histology, other 177 
pathology services (e.g. sputum cytology, urine cytology) and serology and immunology (e.g. 178 
immunoglobin tests, rubella/tuberculin tests). Individual costs, inflated to 2015 prices where 179 
necessary, were assigned to each diagnostic test (e.g. electrocardiogram, diagnostic bone 180 
marrow extraction etc.). 181 
 182 
Secondary care costing 183 
Secondary care encounters were derived from HES inpatient and outpatient data. HES inpatient 184 
data were extracted and each hospital admission was identified by a unique spell number. HES 185 
inpatient data were then reformatted to apply appropriate reference costs to admissions using 186 
the national tariff prices, based on the national average unit service provision costs taken from 187 
the 2015 National Schedule of Reference Costs.(18) This was achieved by using the 188 
hierarchical algorithm in the Health Resource Group (HRG) 4 2015/16 Local Payment Grouper 189 
programme,(21) provided by the Health and Social Care Information Centre (HSCIC). This 190 
programme applied HRG codes to care episodes, which were linked to NHS tariff costs.(18) 191 
HRG codes were generated for each episode of inpatient care experienced by children, and the 192 
sum of NHS tariff costs for these episodes was calculated for each child. 193 
 194 
HES outpatient data were extracted by the CPRD Knowledge Centre.(11) 3.4% of outpatient 195 
episodes were costed using the HSCIC Grouper, while the majority (90.7%) of outpatient 196 
episodes were costed using treatment specialty average costs from the relevant NHS reference 197 
cost schedules. The remaining 5.9% of episodes had an average outpatient cost applied 198 
(£147.30) as they could not be costed by Grouper or treatment speciality. Reference costs for 199 
secondary NHS care in the UK are calculated on a full absorption costing basis and encompass 200 
staff salaries, on-costs, equipment, consumables and revenue and capital overheads. 201 
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 202 
Statistical Analysis 203 
Our primary aim was to compare healthcare costs amongst children born to women who 204 
smoked and non-smokers in pregnancy within the first, the first five and the first 10 years of 205 
life; hence, findings are presented in cohorts with at least 1, 5 or 10 years of follow-up data 206 
available. Descriptive statistics of baseline maternal demographic characteristics for 207 
pregnancies were calculated, including the numbers of children with 1, 5 and 10 years of cohort 208 
data available, and the proportions of each born to smoking and non-smoking mothers. 209 
 210 
Poisson regression was used to compute annualised rate ratios and 95% confidence intervals 211 
(CIs) for the association between smoking status and each component of primary and secondary 212 
healthcare. Numbers of primary and secondary care healthcare episodes used were collapsed 213 
into counts which were analysed cross-sectionally in these Poisson models. The analysis was 214 
stratified by factors considered to potentially affect children’s health care use: maternal age 215 
(<20, 20-24, 25-29, 30-34 and ≥35 years), parity (0 or ≥1 children), socio-economic status 216 
(IMD quintiles), sex of infant (male, female) and mode of delivery (spontaneous, assisted, 217 
elective caesarean, emergency caesarean). Furthermore, year of birth was adjusted for to allow 218 
for the possibility that the volume and or pattern of health care provided to infants and children 219 
might have evolved through the course of each cohort, as well as the recorded prevalence of 220 
maternal smoking. As analyses employed multiple significance testing of strata on the same 221 
healthcare outcome, a Bonferroni correction was applied to tests at the 99.7% confidence level 222 
(i.e. α=0.05/19, p≤0.003, 19 = number of significance tests per outcome) to determine the 223 
significance of each association. The mean and standard deviations for the number of 224 
encounters were also calculated for each stratum.  225 
 226 
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Linear regression was used to compute coefficients and 95% CIs for the association between 227 
maternal smoking during pregnancy and the estimated costs of child healthcare utilisation, 228 
adjusting for year of birth. The absolute difference in average annual cost between children of 229 
smoking and non-smoking mothers was calculated. A similar Bonferroni correction was 230 
applied to the costs as to the previous analysis of healthcare utilisation. In supplementary 231 
material, findings are also presented in strata for maternal age, parity, socio-economic status, 232 
sex of child and delivery method. Since little is known about the costs attributable to smoking 233 
in primary and secondary care, especially beyond five years of follow up, this stratified analysis 234 
was carried out to present the findings in a descriptive way by these variables. Stratification of 235 
the follow-up into one, five and 10 year periods was chosen based on prior knowledge; costing 236 
in the first year is important, as utilisation during infancy may be associated with longer term 237 
costs. The first five years is a marker that is commonly used in the UK and by the WHO 238 
partially as children start formal schooling around age five and allows a comparison to other 239 
studies, and 10 year follow-up was the longest available with a significant number of 240 
participants to analyse. 241 
 242 
In each cohort the variation in total health care costs for children of women who smoked in 243 
pregnancy, versus those who did not, was assessed using a multivariable generalised linear 244 
model (GLM) to generate cost coefficients and 95% CIs. The association between smoking in 245 
pregnancy and overall healthcare cost was adjusted for year of birth, maternal age, IMD, parity, 246 
sex of infant and mode of birth. A gamma distribution and fitted robust standard errors were 247 
applied. We further replicated the GLM models over one and five year time horizons, 248 
restricting the sample to those who had complete 10 year data, to investigate whether the effects 249 
of smoking during pregnancy waned or persisted in the reduced sample size with complete 250 
follow-up data.  251 
12 
 
 252 
Where data were missing for the stratification covariates for the multivariable models (maternal 253 
age, socio-economic status, parity, infant gender or mode of delivery) or for outcomes 254 
(described below), individuals were excluded from analyses. A comparative analysis 255 
investigating the distribution of the baseline covariates was performed to investigate whether 256 
removal of these cases biased the sample. Analyses were conducted using Stata 14.0 (Stata 257 
Corp., College Station, TX).258 
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RESULTS 259 
Cohort selection 260 
There were 586,017 pregnancies with ‘up-to-standard’ CPRD-HES data from January 2003 261 
onwards. 244,012 of these women had sufficient data to attribute smoking status within the 262 
pregnancy. 203,159 of these pregnancies had the minimum length of child follow-up (1 year). 263 
137,737 of these children had the necessary HES-linked secondary care data and 44,585 264 
children were randomly excluded as they were siblings and shared a mother. No participants 265 
were excluded due to there being missing data for other baseline maternal covariates. 266 
Therefore, the final cohort comprised 93,152 children, 21.8% of whom were born to women 267 
who had smoked in pregnancy. 268 
 269 
Cohort characteristics 270 
34,260 children had at least 5 years’ and 5,824 at least 10 years’ data. Approximately one fifth 271 
of children in 5 year and 10 year cohorts were children of maternal smokers. The largest 272 
proportion of mothers fell in the 30-34 year age range in each cohort. The proportions of 273 
children exposed to maternal smoking during pregnancy stratified by maternal age, IMD, 274 
parity, infant sex and mode of birth are listed in Table 1. In all three cohorts, women who 275 
smoked during pregnancy were, on average, younger and resided in more deprived areas. A 276 
slightly higher proportion of first time mothers smoked during pregnancy. A higher proportion 277 
of male children were contained in each of the follow-up cohorts and this did not differ by 278 
maternal smoking status. Finally, non-smoking mothers had a lower spontaneous vaginal 279 
delivery rate and a higher proportion had an instrumental delivery or a caesarean section; this 280 
may be attributable to the greater average age of mothers who did not smoke during pregnancy. 281 
 282 
[Insert Table 1 here] 283 
14 
 
 284 
Comparison of healthcare utilisation by smokers’ and non-smokers’ children 285 
Table 2 presents the adjusted annual rate ratios for primary and secondary care healthcare 286 
utilisation by children of smokers compared to non-smokers, stratified by length of follow-up 287 
(≥1 year, ≥5 years’ and ≥10 years’ follow-up)  and adjusted for year of birth, maternal age, 288 
parity, SES, gender of child and delivery method. In the whole cohort, infants exposed to 289 
maternal smoking in pregnancy had higher primary care consultation (RR: 1.015, 95%CI: 290 
1.007-1.022) and inpatient admission (RR: 1.040, 95%CI: 1.020-1.060) rates during the first 291 
year of life. In children for whom at least 5 years’ data were available, those born to pregnant 292 
smokers had higher annual primary care (RR: 1.021, 95%CI: 1.005-1.038) and outpatient 293 
consultation (RR: 1.084, 95%CI: 1.036-1.134) rates, but a lower annual primary care diagnostic 294 
test rate (RR: 0.961, 95%CI: 0.924-0.999) during the first 5 years of life. Finally, in those with 295 
at least 10 years follow-up data, children born to pregnant smokers had higher annual primary 296 
care (RR: 1.062, 95%CI: 1.012-1.114) and outpatient consultation (RR: 1.126, 95%CI: 1.001-297 
1.267) rates during the first 10 years of life. The risk ratios presented in Table 2 stratified by 298 
confounding factors, and Bonferroni-corrected, are presented in Supplementary Tables 1a-c. 299 
 300 
[Insert Table 2 here] 301 
 302 
Comparison of healthcare costs incurred by smokers’ and non-smokers’ children 303 
Table 3 compares overall estimated health care costs incurred by children of women who 304 
smoked and did not smoke in pregnancy, disaggregating costs for different health care 305 
components. All associations were adjusted by year or birth, maternal age, parity, SES, gender 306 
of child and delivery method. 307 
 308 
15 
 
Smoking during pregnancy had the greatest influence on hospital inpatient costs, which were 309 
significantly greater for children whose mothers smoked during pregnancy (β: £93.95, 95%CI: 310 
£39.44-£148.45) during the first year of life. For all other aspects of health care utilisation 311 
(primary care, diagnostic tests, prescriptions, and outpatient care), including for the five and 312 
ten year cohorts, there were no significant differences in costs between the children whose 313 
mothers either smoked or didn’t smoke during pregnancy. The coefficients presented in Table 314 
3 stratified by confounding factors and Bonferroni-corrected, are presented in Supplementary 315 
Tables 2a-c. 316 
 317 
[Insert Table 3 here] 318 
 319 
Investigation of factors influencing costs: multivariable GLM model  320 
Table 4 presents multivariable GLM models for children with at least 1, 5 and 10 years of 321 
follow-up data, with total healthcare costs as the dependant variable. Following adjustment for 322 
year of birth, IMD, parity, sex of child and delivery method, maternal smoking in pregnancy 323 
was associated with significantly higher total healthcare costs during the first (β: £91.18, 324 
95%CI: £47.52-£134.83) and also the first 5 (β: £221.80, 95%CI: £17.78-£425.83) years of 325 
life, but not during the first 10 years (β: 365.94, 95%CI: -192.72-924.60). Over the first year 326 
of life, boys had greater total healthcare costs compared to girls (β: £229.05, 95%CI: £196.00-327 
£262.10), whilst increasing intensity of intervention delivery method was also associated with 328 
greater costs (e.g. emergency caesarean β: £655.39, 95%CI: £599.96-£710.81). Greater socio-329 
economic deprivation was associated with higher costs (5th IMD quintile: β: £79.03, 95%CI: 330 
£26.46-£131.61), but increasing maternal age was associated with lower total health care costs 331 
(e.g. for 30-34 year olds: β: -£117.16, 95%CI: -£167.58- -£66.74). Compared to complete 332 
cohort findings, total health care costs over the first 5 years and first 10 years of life showed 333 
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similar associations with delivery mode, sex of child and IMD distribution. However, whilst 334 
maternal age showed little or no effect on total costs of child healthcare over extended follow-335 
up periods, multiparity was associated with significantly reduced total healthcare costs over the 336 
first 10 years of life (-£645.09, 95%CI: -£1195.04- -£95.14).   337 
 338 
[Insert Table 4 here] 339 
 340 
Following restriction of the GLM models to children with complete 10 years follow-up data, 341 
the associations were similar to those for the unrestricted analysis at one year (β: 41.18, 95%CI: 342 
-£98.02- £180.38) and five  years (β: £195.22, 95%CI: -£165.19- £555.63); however, the cost 343 
coefficients did not reach statistical significance.  344 
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Discussion 345 
Infants and children of pregnant smokers had higher healthcare costs over the first five years 346 
of life, predominantly attributable to greater hospital inpatient care. Although rates of primary 347 
care consultations, hospital inpatient and hospital outpatient episodes were higher in smokers’ 348 
children, our results indicate an inverse association between smoking during pregnancy and the 349 
number of diagnostic tests in primary care during the first five years of children’s lives. This 350 
apparent underutilisation in the use of some primary health care services may reflect 351 
differences in health seeking behaviour between mothers characterised by different 352 
sociodemographic profiles, but this remains to be elucidated by future research studies in this 353 
clinical context. 354 
 355 
Strengths and limitations  356 
Amongst studies evaluating healthcare costs of children born to pregnant smokers, this has the 357 
longest follow-up and is the first to investigate costs after 5 years of life. Additionally, it is 358 
more comprehensive; we attempted to measure use of all healthcare rather than, as in previous 359 
studies, only assessing impacts generated by selected conditions thought to be associated with 360 
smoking in pregnancy (7) or taking only a secondary care perspective.(9) We believe this work 361 
is the first to use multivariable methods to identify key influences on children’s smoking-362 
attributable healthcare costs. 363 
 364 
A limitation is that we defined the smoking status in pregnancy from records of tobacco use 365 
and of smoking cessation medication prescriptions in medical records and this involved some 366 
assumptions. Some women stop smoking later in pregnancy but our simplified classification 367 
of women as either ‘smoking’ or ‘not smoking’ for the whole of pregnancy could not reflect 368 
this and some women may have been categorised as smoking throughout pregnancy when they 369 
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may only have smoked briefly. However, patients usually provide accurate information to 370 
General Practitioners and we have previously demonstrated that assumptions used in this study 371 
lead to valid attribution of smoking status (15), so any misclassification of smoking will be 372 
small and study findings are likely to be valid. Additionally, as misclassification would tend to 373 
reduce apparent differences between groups’ healthcare cost estimates, findings are 374 
conservative and actual cost differences may be larger. A further limitation was the absence of 375 
comprehensive data on the number of cigarettes smoked during pregnancy. As data on this 376 
variable were only available in the records of 22% of women, we did not account for this factor 377 
as this would have reduced the sample size and precision of estimates, especially for the 378 
analyses over an extended time horizon for which we had fewer complete cases.  379 
 380 
As women who smoke in pregnancy are likely to smoke after childbirth, some of infants’ and 381 
children’s healthcare use in the smoking-exposed group may be attributable to second hand 382 
smoking (SHS). We decided not to attempt to factor this into our analyses as smoking data 383 
were inconsistently recorded at varied time points and even where these data were available it 384 
was not possible to ascertain whether infants’ exposure to parental smoking had occurred. 385 
Although the extent of children’s SHS exposure in this cohort is not known, we do not 386 
anticipate that this will have a marked effect, as in the UK since 2007, the percentage of 387 
children exposed to SHS for ‘at least one hour a week’ has remained static at about 11%.(22) 388 
SHS exposure may have been more prevalent at the start of the cohort but it seems unlikely 389 
that this will have had a substantial impact on findings; nevertheless, our cost estimates are 390 
probably best viewed as those which could be avoided if smoking in pregnancy was 391 
permanently eliminated and women remained abstinent after childbirth.  392 
 393 
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We cannot discount the possibility that there are unobserved clinical and behavioural 394 
characteristics that are positively correlated with both smoking in pregnancy and economic 395 
outcomes and not accounting for them in the models may have biased upwards the apparent 396 
effect of smoking. A number of clinical conditions that increase the risk of poor birth outcomes 397 
with long-term sequelae, such as gestational hypertension,(23, 24) are likely to have been 398 
present with the sample. Similarly, we did not adjust for other risky behaviours associated with 399 
smoking in pregnancy such as illicit drug or alcohol use. Illicit drug use is not recorded reliably 400 
in routinely collected electronic medical records and may be treated in specialist facilities not 401 
covered by primary and secondary care records, whilst the GP enhanced services contract 402 
provides an opt-out clause to not be involved in the treatment of drug dependence.(25) As a 403 
result, drug dependence could have been differentially recorded during the study period and 404 
thus we could not adjust for it reliably. Similarly, alcohol use during pregnancy is poorly 405 
recorded and has low prevalence (6.8%)(26) and there is some evidence of systematic 406 
misclassification in routinely recorded data by doctors.(27) Therefore, the effects of illicit drug 407 
and alcohol use were not explicitly accounted for. However, drug and alcohol related problems 408 
are very strongly associated with socio-economic deprivation, and we did adjust for this in the 409 
form of IMD scores in all of our analyses, which as a proxy for these factors may have reduced 410 
this bias. 411 
 412 
Another limitation derives from linked HES data only having being available for 12 years 413 
resulting in relatively few children having 10 years’ follow-up data, a comparatively small 10-414 
year cohort and analyses at this time point having limited power. Restricting the analyses for 415 
total costs at one and five years to a group with 10 year follow-up data found that, although the 416 
associations were similar to those for the unrestricted analysis, the cost coefficients did not 417 
reach statistical significance. This may have been due to an insufficient sample size rather than 418 
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a proven waning of the effect of smoking during pregnancy. Future, bigger studies might be 419 
necessary for a more definitive investigation of findings at 10-year follow up. Nevertheless, 420 
this cohort has a substantially longer follow-up period than the previous longest study and as 421 
such is a substantial contribution to the literature.(9) 422 
 423 
Results in context  424 
Petrou et al. estimated mean hospital inpatient cost differences between children born to 425 
smokers and non-smokers as £138, £307 and £462 over the first 5 years of life in women who 426 
reported smoking 1-9, 10-19 or ≥20 cigarettes, respectively.(9) Although these cost estimates 427 
were derived from hospital inpatient data extracted from a limited geographical area of England 428 
(Oxford Record Linkage Study), they are broadly similar in magnitude to the mean total 429 
healthcare cost differences we generated (multivariable model at 5 years: £221.80 (£17.78-430 
£425.83)). This may reflect our finding that overall healthcare costs were most strongly 431 
influenced by hospital admissions. Godfrey et al. investigated average costs for maternal 432 
outcomes and infant outcomes attributable to smoking and non-smoking in pregnancy.(7) 433 
Using literature based unit costs, infant outcomes over the first year of life related to smoking 434 
in pregnancy were estimated to cost the NHS £12-£23.5 million per year. Our multivariable 435 
model generated a mean incremental child healthcare cost attributable to maternal smoking 436 
during pregnancy of £91.18 (£47.52-£134.83) over the first year of life. Assuming 437 
approximately 700,000 pregnancies per year and a UK prevalence of smoking during 438 
pregnancy of 15%(28, 29) this translates to an additional annual health care cost of £9.6 (£4.9-439 
£14.1) million when the health sequelae of smoking during pregnancy are restricted to those 440 
experienced during the first year of life. This represents a more conservative estimate of costs 441 
attributable to smoking during pregnancy compared to those derived from the published 442 
literature. When the health sequelae of smoking during pregnancy are extended to the first 5 443 
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years of life, additional annual health care costs increase to £23.3 (£1.9-£44.7) million. Overall 444 
findings from this direct analysis of health care use suggest that excess infant health care costs 445 
attributable to maternal smoking in pregnancy are smaller than previously estimated. Actual 446 
costs could be higher or lower than point estimates though because, as previously noted, biases 447 
within analyses might inflate or reduce the derived point estimates.  448 
 449 
Although health benefit remains the principal reason for encouraging smoking cessation in 450 
pregnancy, findings suggest that smoking cessation in pregnancy is also likely to lessen the 451 
costs of providing healthcare to children. When assessing the potential economic benefits of 452 
providing stop smoking services for pregnant women, any reduction in maternal healthcare 453 
costs associated with smoking during pregnancy should be considered in addition to the infant 454 
and childhood ones we have quantified. For example, recent estimates suggest that English 455 
NHS Stop Smoking Services cost £235 per quitter (29) so most of the investment made 456 
providing such services could be recouped in the medium term by the reduced spending on 457 
infant’s and children’s health care generated by the smoking cessation which these services 458 
promote. Indeed, adding in any reductions in the costs of providing healthcare to pregnant 459 
women who stop smoking permanently, the provision of cessation support in pregnancy could 460 
even be cost-saving to a health system.   461 
 462 
Conclusions 463 
Maternal smoking in pregnancy is a leading preventable cause of harm to mothers and babies, 464 
and we found that it is associated with increased children’s healthcare costs over the first 5 465 
years of life, with elevated costs primarily driven by more costly hospital admissions. Findings 466 
imply that funding cessation support for pregnant smokers could have economic benefits in 467 
addition those health benefits which accrue from permanent smoking cessation in pregnancy. 468 
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Table 1. Maternal and child characteristics according to mother’s smoking status 
during pregnancy 
  At least 1 year's follow-up†  At least 5 years' follow-up  At least 10 years' follow-up  
    Non-smokers (%) Smokers (%) Non-smokers (%) Smokers (%) Non-smokers (%) Smokers (%)   
Overall 72863 (78.2)* 20289 (21.8)*  26958 (78.7)* 7302 (21.3)*  4666 (80.1)* 1158 (19.9)*  
           
Maternal age (years)          
 <20 2475 (3.4) 2188 (10.8)  797 (3.0) 790 (10.8)  121 (2.6) 105 (9.1)  
 20-24 9298 (12.8) 5548 (27.3)  3178 (11.8) 1879 (25.7)  538 (11.5) 273 (23.6)  
 25-29 19352 (26.6) 5516 (27.2)  6693 (24.8) 1871 (25.6)  1128 (24.2) 304 (26.3)  
 30-34 24690 (33.9) 4368 (21.5)  9224 (34.2) 1655 (22.7)  1668 (35.8) 305 (26.3)  
 ≥35 17048 (23.4) 2669 (13.2)  7066 (26.2) 1107 (15.2)  1211 (26.0) 171 (14.8)  
Socio-economic status: Index of Multiple 
Deprivation          
 1 (least deprived) 18142 (24.9) 2585 (12.7)  7550 (28.0) 1019 (14.0)  1442 (30.9) 174 (15.0)  
 2 15735 (21.6) 3195 (15.8)  6053 (22.5) 1203 (16.5)  1110 (23.8) 197 (17.0)  
 3 13872 (19.0) 3855 (19.0)  5028 (18.7) 1376 (18.8)  864 (18.5) 232 (20.0)  
 4 13789 (18.9) 4968 (24.5)  4668 (17.3) 1788 (24.5)  735 (15.8) 278 (24.0)  
 5 (most deprived) 11325 (15.5) 5686 (28.0)  3659 (13.6) 1916 (26.2)  515 (11.0) 277 (23.9)  
Parity          
 0 42358 (58.1) 12370 (61.0)  11774 (43.7) 3370 (46.2)  1842 (39.5) 461 (39.8)  
 ≥1 30505 (41.9) 7919 (39.0)  15184 (56.3) 3932 (53.9)  2824 (60.5) 697 (60.2)  
Sex of child          
 Female 34585 (47.5) 9620 (47.4)  12533 (46.5) 3411 (46.7)  2107 (45.2) 543 (46.9)  
 Male 38278 (52.5) 10669 (52.6)  14425 (53.5) 3891 (53.3)  2559 (54.8) 615 (53.1)  
Delivery method          
 Spontaneous vaginal delivery 42756 (58.7) 13068 (64.4)  15999 (59.4) 4736 (64.9)  2729 (58.5) 756 (65.3)  
 Assisted delivery 10693 (14.7) 2513 (12.4)  3491 (13.0) 848 (11.6)  618 (13.2) 126 (10.9)  
 Elective caesarean 7769 (10.7) 1724 (8.5)  3178 (11.8) 658 (9.0)  575 (12.3) 108 (9.3)  
  Emergency caesarean 11645 (16.0) 2984 (14.7)   4290 (15.9) 1060 (14.5)   744 (16.0) 168 (14.5)   
*Row percentage, otherwise column percentage   
†Follow-up at one year constitutes entire study cohort        
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Table 2. Adjusted annual rate ratios for primary and secondary healthcare utilisation for children whose mothers were smokers compared to non-
smokers during pregnancy 
  Number of Primary Care 
consultations, Mean (Median) 
   
   95% CI 
    Non-smoking Smoking RR* lower upper 
(0-1 years follow-up for those with at least 1 year follow-up data) (N=93,152) 12.17 (10) 12.36 (11) 1.015 1.007 1.022 
(0-5 years follow-up for those with at least 5 years follow-up data) (N=34,260) 31.59 (27) 32.17 (27) 1.021 1.005 1.038 
(0-10 years follow-up for those with at least 10 years follow-up data) (N=5,824) 42.73 (35) 45.57 (37) 1.062 1.012 1.114 
  Number of prescriptions, Mean 
(Median) 
   
   95% CI 
  Non-smoking Smoking 
RR* lower upper 
(0-1 years follow-up for those with at least 1 year follow-up data) (N=93,152) 5.04 (3) 5.15 (3) 1.005 0.994 1.016 
(0-5 years follow-up for those with at least 5 years follow-up data) (N=34,260) 15.62 (10) 15.45 (11) 0.980 0.959 1.003 
(0-10 years follow-up for those with at least 10 years follow-up data) (N=5,824) 23.71 (15) 24.64 (17) 1.016 0.953 1.084 
  Number of diagnostic tests, Mean 
(Median) 
   
   95% CI 
  Non-smoking Smoking 
RR* lower upper 
(0-1 years follow-up for those with at least 1 year follow-up data) (N=93,152) 2.26 (1) 2.19 (1) 0.990 0.974 1.006 
(0-5 years follow-up for those with at least 5 years follow-up data) (N=34,260) 5.56 (1) 5.32 (1) 0.961 0.924 0.999 
(0-10 years follow-up for those with at least 10 years follow-up data) (N=5,824) 9.33 (2) 9.98 (3) 1.078 0.974 1.193 
  Inpatient, Mean (Median)**  95% CI 
  Non-smoking Smoking 
RR* lower upper 
(0-1 years follow-up for those with at least 1 year follow-up data) (N=93,152) 1.54 (1) 1.63 (1) 1.040 1.020 1.060 
(0-5 years follow-up for those with at least 5 years follow-up data) (N=34,260) 2.09 (1) 2.27 (1) 1.048 0.986 1.114 
(0-10 years follow-up for those with at least 10 years follow-up data) (N=5,824) 2.38 (1) 2.60 (2) 1.062 0.869 1.298 
  Outpatient, Mean (Median)**  95% CI 
   Non-smoking Smoking 
RR* lower upper 
(0-1 years follow-up for those with at least 1 year follow-up data) (N=93,152) 1.11 (0) 1.07 (0) 1.004 0.981 1.028 
(0-5 years follow-up for those with at least 5 years follow-up data) (N=34,260) 3.84 (1) 4.13 (1) 1.084 1.036 1.134 
(0-10 years follow-up for those with at least 10 years follow-up data) (N=5,824) 6.65 (2) 7.63 (3) 1.126 1.001 1.267 
*Poisson regression RR (95%CI) for number of consultations per year of follow-up, adjusted for year of birth, maternal age, parity, SES, gender of child and 
delivery method 
** Secondary care consultations      
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Risk ratios in bold font are significant at p≤0.003 
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Table 3. Primary care, secondary care and overall costs of healthcare utilisation accrued for children whose mothers were smokers compared to non-
smokers during pregnancy 
  Cost of Primary Care consultations, 
Mean (Median)* 
   
   95% CI 
  Non-smoking Smoking 
β lower upper 
Costs for children at 1 year with at least 1 year of follow-up (N=93,152) 192 (166) 193 (167) 1.11 -1.86 4.07 
Costs for children at 5 years with at least 5 years of follow-up (N=34,260) 508 (435) 513 (440) 6.97 -6.60 20.56 
Costs for children at 10 years with at least 10 years of follow-up (N=5,824) 705 (592) 742.12 (634) 31.62 -16.59 79.84 
  Cost of prescriptions, Mean 
(Median)* 
   
   95% CI 
  Non-smoking Smoking 
β lower upper 
Costs for children at 1 year with at least 1 year of follow-up (N=93,152) 324 (177) 330 (187) 0.30 -11.81 12.40 
Costs for children at 5 years with at least 5 years of follow-up (N=34,260) 1063 (588) 1060 (617) -6.51 -85.10 72.08 
Costs for children at 10 years with at least 10 years of follow-up (N=5,824) 1781 (868) 1847 (1028) 29.84 -362.67 422.36 
  Cost of diagnostic tests, Mean 
(Median)* 
   
   95% CI 
  Non-smoking Smoking 
β lower upper 
Costs for children at 1 year with at least 1 year of follow-up (N=93,152) 21 (0) 22 (0) 1.72 -0.27 3.71 
Costs for children at 5 years with at least 5 years of follow-up (N=34,260) 56 (4) 56 (1) 0.24 -6.88 7.36 
Costs for children at 10 years with at least 10 years of follow-up (N=5,824) 124 (14) 126 (14) 0.18 -40.77 41.14 
  Inpatient, Mean (Median)*  95% CI 
  Non-smoking Smoking 
β lower upper 
Costs for children at 1 year with at least 1 year of follow-up (N=93,152) 755 (0) 862 (0) 93.95 39.44 148.45 
Costs for children at 5 years with at least 5 years of follow-up (N=34,260) 1299 (0) 1526 (604) 173.41 -44.83 391.65 
Costs for children at 10 years with at least 10 years of follow-up (N=5,824) 1620 (595) 1841 (731) 152.69 -489.51 794.90 
  Outpatient, Mean (Median)*  95% CI 
  Non-smoking Smoking 
β lower upper 
Costs for children at 1 year with at least 1 year of follow-up (N=93,152) 189 (0) 183 (0) 3.06 -8.62 14.73 
Costs for children at 5 years with at least 5 years of follow-up (N=34,260) 605 (193) 659 (193) 52.58 -5.47 110.62 
Costs for children at 10 years with at least 10 years of follow-up (N=5,824) 1014 (382) 1181 (500) 135.10 -81.34 351.54 
*regression coefficients for cost (£) adjusted for year of birth, maternal age, SES, parity, 
gender of child and delivery method      
Coefficients in bold font are significant at p≤0.003      
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Table 4. Multivariable GLM models for total costs incurred by 1 year, 5 years and 10 years follow-up      
Variables Total Costs, 0-1 years (N=93,152) 
 
Total Costs, 0-5 years (N=34,260) 
 
Total Costs, 0-10 years (N=5,824) 
  
 
95% CI 
   
95% CI 
 
 
 
95% CI 
 
    β lower upper p<0.05   β lower upper p<0.05   β lower upper p<0.05 
Maternal smoking during pregnancy 91.18 47.52 134.83 <0.001  221.80 17.78 425.83 0.033  365.94 -192.72 924.60 0.199 
Year of birth 25.43 20.03 30.84 <0.001  10.96 -25.49 47.41 0.556  -221.99 -613.69 169.71 0.267 
Maternal age (years)               
 <20 72.12 -52.03 196.26 0.255  268.01 -204.67 740.68 0.266  929.13 -515.37 2373.63 0.207 
 20-24 0.00 - - -  0.00 - - -  0.00 - - - 
 25-29 -86.11 -137.64 -34.59 0.001  -176.53 -462.52 109.46 0.226  275.07 -413.62 963.77 0.434 
 30-34 -117.16 -167.58 -66.74 <0.001  -273.43 -542.96 -3.91 0.047  -46.98 -638.91 544.95 0.876 
 ≥35 -54.26 -112.71 4.19 0.069  -75.41 -365.00 214.19 0.610  -50.04 -773.58 673.50 0.892 
Socio-economic status: Index of Multiple Deprivation          
 1 (least deprived) 0.00 - - -  0.00 - - -  0.00 - - - 
 2 67.83 17.18 118.48 0.009  -114.12 -305.36 77.12 0.242  111.25 -562.81 785.30 0.746 
 3 18.74 -28.97 66.45 0.441  87.01 -151.44 325.46 0.474  0.02 -732.92 732.97 1.000 
 4 18.07 -32.78 68.92 0.486  96.77 -131.51 325.05 0.406  289.73 -394.88 974.35 0.407 
 5 (most deprived) 79.03 26.46 131.61 0.003  295.80 56.61 534.98 0.015  996.54 205.62 1787.46 0.014 
Parity               
 0 0.00 - - -  0.00 - - -  0.00 - - - 
 ≥1 25.63 -9.54 60.80 0.153  95.50 -49.02 240.02 0.195  -645.09 -1195.04 -95.14 0.022 
Sex of child               
 Female 0.00 - - -  0.00 - - -  0.00 - - - 
 Male 229.05 196.00 262.10 <0.001  465.22 320.74 609.70 <0.001  1140.25 650.11 1630.40 <0.001 
Delivery method               
 Spontaneous vaginal delivery 0.00 - - -  0.00 - - -  0.00 - - - 
 Assisted delivery 299.98 247.48 352.47 <0.001  619.49 364.87 874.11 <0.001  588.17 -116.89 1293.23 0.102 
 Elective caesarean 371.81 304.12 439.49 <0.001  886.30 583.07 1189.53 <0.001  704.27 -21.35 1429.88 0.057 
  Emergency caesarean 655.39 599.96 710.81 <0.001   1275.37 1022.32 1528.42 <0.001   1483.91 679.90 2287.91 <0.001 
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